Corbenic Partners’s Novo Nordisk NVO Stock Holding History

Corbenic Partners’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,260	Closed	-$27K	–	195
2014 Q4	$27K	Buy	+1,260	New	+$28.1K	0.02%	78

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Corbenic Partners's NVO Position: Q1 2015 in Review

Corbenic Partners sold out of Novo Nordisk (NVO) in Q1 2015, closing a stake of 1,260 shares — an estimated $27K sold.

Corbenic Partners first reported a position in NVO in Q4 2014 and held it in 1 quarter. The position peaked at $27K in Q4 2014. 505 funds tracked by Wall St. Rank hold NVO as of Q1 2015.

Corbenic Partners reported no remaining Novo Nordisk position as of Q1 2015 after selling out during the quarter.
Corbenic Partners sold 1,260 Novo Nordisk shares in Q1 2015, an estimated $27K.
Corbenic Partners first reported a position in Novo Nordisk in Q4 2014 and held it in 1 quarter.
Corbenic Partners's Novo Nordisk position peaked at $27K in Q4 2014.
505 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2015.

Based on Corbenic Partners's 13F filing for Q1 2015, filed 16 Apr 2015.